<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>1418</number>
    <updateDate>2025-10-07T23:19:42Z</updateDate>
    <updateDateIncludingText>2025-10-07T23:19:42Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2023-03-07</introducedDate>
    <congress>118</congress>
    <legislationUrl>https://www.congress.gov/bill/118th-congress/house-bill/1418</legislationUrl>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 169, Number 43 (Tuesday, March 7, 2023)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. PENCE:H.R. 1418.Congress has the power to enact this legislation pursuantto the following:Article 1 Section 8 Clause 3 of the U.S. ConstitutionThe single subject of this legislation is:To amend the Federal Food, Drug, and Cosmetic Act toreauthorize user fee programs relating to new animal drugsand generic new animal drugs.[Page H1152]&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Reported by</name>
                <date>2023-05-17T20:40:30Z</date>
              </item>
              <item>
                <name>Markup by</name>
                <date>2023-05-17T20:40:04Z</date>
              </item>
              <item>
                <name>Referred to</name>
                <date>2023-03-17T18:24:56Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Reported By</name>
            <date>2023-06-09T15:09:13Z</date>
          </item>
          <item>
            <name>Markup By</name>
            <date>2023-05-24T17:59:42Z</date>
          </item>
          <item>
            <name>Referred To</name>
            <date>2023-03-07T17:01:50Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 118-104</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2023</title>
        <congress>118</congress>
        <number>1844</number>
        <type>S</type>
        <latestAction>
          <actionDate>2023-07-26</actionDate>
          <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Continuing Appropriations Act, 2024 and Other Extensions Act</title>
        <congress>118</congress>
        <number>5860</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2023-09-30</actionDate>
          <text>Became Public Law No: 118-15.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2023-09-20</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 210.</text>
        <type>Calendars</type>
      </item>
      <item>
        <actionDate>2023-07-18</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2023-07-17</actionDate>
        <actionTime>16:50:41</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-07-17</actionDate>
        <actionTime>16:50:39</actionTime>
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H3620-3623)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-07-17</actionDate>
        <actionTime>16:50:39</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H3620-3623)</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-07-17</actionDate>
        <actionTime>16:40:25</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 1418.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-07-17</actionDate>
        <actionTime>16:40:24</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H3620-3624)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-07-17</actionDate>
        <actionTime>16:40:11</actionTime>
        <text>Mr. Bilirakis moved to suspend the rules and pass the bill, as amended.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-06-09</actionDate>
        <text>Placed on the Union Calendar, Calendar No. 80.</text>
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <calendarNumber>
          <calendar>U00080</calendar>
        </calendarNumber>
      </item>
      <item>
        <actionDate>2023-06-09</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-104.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-06-09</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-104.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-05-24</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-05-24</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-05-17</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by the Yeas and Nays: 29 - 0 .</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-05-17</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Subcommittee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-03-17</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-03-07</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-03-07</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-03-07</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>P000615</bioguideId>
        <fullName>Rep. Pence, Greg [R-IN-6]</fullName>
        <firstName>Greg</firstName>
        <lastName>Pence</lastName>
        <party>R</party>
        <state>IN</state>
        <district>6</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>S001216</bioguideId>
        <fullName>Rep. Schrier, Kim [D-WA-8]</fullName>
        <firstName>Kim</firstName>
        <lastName>Schrier</lastName>
        <party>D</party>
        <state>WA</state>
        <district>8</district>
        <sponsorshipDate>2023-03-07</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000590</bioguideId>
        <fullName>Rep. Lee, Susie [D-NV-3]</fullName>
        <firstName>Susie</firstName>
        <lastName>Lee</lastName>
        <party>D</party>
        <state>NV</state>
        <district>3</district>
        <sponsorshipDate>2023-06-06</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Research and development</name>
          <updateDate>2023-05-26T15:15:20Z</updateDate>
        </item>
        <item>
          <name>User charges and fees</name>
          <updateDate>2023-05-26T15:15:20Z</updateDate>
        </item>
        <item>
          <name>Veterinary medicine and animal diseases</name>
          <updateDate>2023-05-26T15:15:20Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2023-03-29T17:18:42Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-03-07</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2023-07-19T16:57:39Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;b&gt;Animal Drug User Fee Amendments of 2023&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill reauthorizes the Food and Drug Administration (FDA) to collect fees for brand-name and generic animal drug applications through FY2028. It also makes related updates to fee calculations and FDA reporting requirements. &lt;/p&gt; &lt;p&gt;The bill also provides for a specific fee for requests to establish generic investigational new animal drug files and requires other application fees to be adjusted accordingly.&lt;/p&gt; &lt;p&gt;Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the FDA before they may be offered on the commercial market. The FDA is authorized to collect fees for animal drug applications in order to support its regulatory activities; this authority currently expires at the end of FY2023.&lt;/p&gt;</text>
        </cdata>
      </summary>
      <summary>
        <versionCode>07</versionCode>
        <actionDate>2023-06-09</actionDate>
        <actionDesc>Reported to House</actionDesc>
        <updateDate>2023-09-20T20:00:24Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;b&gt;Animal Drug and Animal Generic Drug User Fee Amendments of 2023&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill reauthorizes the Food and Drug Administration (FDA) to collect fees for brand-name and generic animal drug applications through FY2028. It also makes related updates to fee calculations and FDA reporting requirements. &lt;/p&gt; &lt;p&gt;The bill also (1) provides for a specific fee for requests to establish generic investigational new animal drug files and requires other application fees to be adjusted accordingly; (2) authorizes the FDA to remove species from the definition of &lt;i&gt;major species&lt;/i&gt; (currently horses, dogs, cats, cattle, pigs, chickens, and turkeys); and (3) provides statutory authority for FDA to report on its progress supporting antimicrobial stewardship in veterinary settings (i.e., supporting responsible use of antimicrobial drugs for animals to slow the development of drug-resistant bacteria).&lt;/p&gt; &lt;p&gt;Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the FDA before they may be offered on the commercial market. The FDA is authorized to collect fees for animal drug applications in order to support its regulatory activities; this authority currently expires at the end of FY2023.&lt;/p&gt;</text>
        </cdata>
      </summary>
      <summary>
        <versionCode>53</versionCode>
        <actionDate>2023-07-17</actionDate>
        <actionDesc>Passed House</actionDesc>
        <updateDate>2023-09-22T18:26:54Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;b&gt;Animal Drug and Animal Generic Drug User Fee Amendments of 2023&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill reauthorizes the Food and Drug Administration (FDA) to collect fees for brand-name and generic animal drug applications through FY2028. It also makes related updates to fee calculations and FDA reporting requirements. &lt;/p&gt; &lt;p&gt;The bill also (1) provides for a specific fee for requests to establish generic investigational new animal drug files and requires other application fees to be adjusted accordingly; (2) authorizes the FDA to remove species from the definition of &lt;i&gt;major species&lt;/i&gt; (currently horses, dogs, cats, cattle, pigs, chickens, and turkeys); and (3) provides statutory authority for the FDA to report on its progress supporting antimicrobial stewardship in veterinary settings (i.e., supporting responsible use of antimicrobial drugs for animals to slow the development of drug-resistant bacteria).&lt;/p&gt; &lt;p&gt;Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the FDA before they may be offered on the commercial market. The FDA is authorized to collect fees for animal drug applications in order to support its regulatory activities; this authority currently expires at the end of FY2023.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2023</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-07-24T15:18:17Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) from PCS (Placed on Senate Calendar) bill text</titleType>
        <titleTypeCode>152</titleTypeCode>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-07-24T15:14:32Z</updateDate>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Placed on Calendar Senate</billTextVersionName>
        <billTextVersionCode>PCS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles for portions of this bill from PCS (Placed on Senate Calendar) bill text</titleType>
        <titleTypeCode>151</titleTypeCode>
        <title>Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-07-24T15:14:32Z</updateDate>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Placed on Calendar Senate</billTextVersionName>
        <billTextVersionCode>PCS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles for portions of this bill from PCS (Placed on Senate Calendar) bill text</titleType>
        <titleTypeCode>151</titleTypeCode>
        <title>Animal Drug User Fee Amendments of 2023</title>
        <updateDate>2024-07-24T15:14:32Z</updateDate>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Placed on Calendar Senate</billTextVersionName>
        <billTextVersionCode>PCS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced for portions of this bill</titleType>
        <titleTypeCode>106</titleTypeCode>
        <title>Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:41:47Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Animal Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:41:47Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced for portions of this bill</titleType>
        <titleTypeCode>106</titleTypeCode>
        <title>Animal Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:41:47Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to House for portions of this bill</titleType>
        <titleTypeCode>107</titleTypeCode>
        <title>Animal Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:39:37Z</updateDate>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to House for portions of this bill</titleType>
        <titleTypeCode>107</titleTypeCode>
        <title>Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:39:37Z</updateDate>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to House</titleType>
        <titleTypeCode>102</titleTypeCode>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:39:37Z</updateDate>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Passed House</titleType>
        <titleTypeCode>104</titleTypeCode>
        <title>Animal Drug and Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:38:34Z</updateDate>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Engrossed in House</billTextVersionName>
        <billTextVersionCode>EH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Passed House for portions of this bill</titleType>
        <titleTypeCode>109</titleTypeCode>
        <title>Animal Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:38:34Z</updateDate>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Engrossed in House</billTextVersionName>
        <billTextVersionCode>EH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Passed House for portions of this bill</titleType>
        <titleTypeCode>109</titleTypeCode>
        <title>Animal Generic Drug User Fee Amendments of 2023</title>
        <updateDate>2024-05-24T13:38:34Z</updateDate>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Engrossed in House</billTextVersionName>
        <billTextVersionCode>EH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs.</title>
        <updateDate>2024-03-18T20:58:14Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Placed on Calendar Senate</type>
        <date>2023-09-20T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr1418pcs/xml/BILLS-118hr1418pcs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Engrossed in House</type>
        <date>2023-07-17T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr1418eh/xml/BILLS-118hr1418eh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Reported in House</type>
        <date>2023-06-09T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr1418rh/xml/BILLS-118hr1418rh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2023-03-07T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr1418ih/xml/BILLS-118hr1418ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-09-20</actionDate>
      <text>Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 210.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
